Source link : https://www.newshealth.biz/health-news/fda-okays-abuse-deterrent-opioid-for-severe-pain/
The US Food and Drug Administration (FDA) has approved a 10-mg dose of Roxybond (Protega Pharmaceuticals), an opioid analgesic indicated for the management of severe pain in cases where other treatments are not well-tolerated or prove ineffective. Roxybond, an immediate-release (IR) formulation of oxycodone hydrochloride, is made with Protega’s SentryBond technology, which makes it harder for […]
Author : News Health
Publish date : 2024-10-31 09:43:34
Copyright for syndicated content belongs to the linked Source.
